Advarra recently introduced Braid, an advanced AI engine designed to revolutionize operational intelligence and workflow automation within clinical trials. As a prominent player in regulatory reviews and clinical research technology, Advarra leverages Braid to provide stakeholders such as sponsors, contract research organizations (CROs), and trial sites with valuable insights and automation capabilities. What distinguishes Braid is its foundation, which draws from a vast and detailed clinical trial operations dataset, including data from over 30,000 studies conducted by 3,500 sponsors. By integrating operational data with standardized ontologies, Braid offers unparalleled analytical and agentic functionalities.
One of the key features of Braid is its ability to unlock operational data throughout the entire trial lifecycle, enabling the capture of crucial milestones and insights as studies progress. This continuous data access allows for the identification of trends, patterns, and areas of improvement, ultimately enhancing the planning, execution, and scalability of research endeavors. By reducing the burden on study teams, sites, and patients, Braid facilitates more coordinated research efforts and supports evidence-based decision-making in trial planning. Additionally, Braid’s automation capabilities streamline workflows and enhance operational efficiency across various systems.
Advarra’s commitment to leveraging AI in clinical trials stems from the belief that while critical decisions related to ethics and participant protection remain human-driven, AI can significantly enhance operational processes and support research stakeholders effectively. Through ongoing investments in AI capabilities and technology leadership, Advarra aims to transform the landscape of clinical trials by introducing innovative solutions powered by Braid. For example, upcoming products will focus on enhancing study design by providing data-driven insights and benchmarks to optimize protocol engineering, align study designs with operational realities, and reduce costs and timelines.
The application of Braid by Advarra extends beyond improving study design, with plans to address a variety of use cases in the clinical trial ecosystem. By breaking down silos that often impede research progress, Advarra aims to create a connected ecosystem where patients, sites, sponsors, and CROs collaborate seamlessly to accelerate trial processes. Recognized as a trusted partner by the top global biopharma sponsors, CROs, and site investigators, Advarra’s innovative approach to integrating AI into clinical trial operations underscores its commitment to advancing research efficiency, ethics, and compliance while fostering a culture of continuous improvement and operational excellence.
Key Takeaways:
– Braid by Advarra leverages AI to unlock operational intelligence and automate workflows in clinical trials, enabling stakeholders to optimize research processes and decision-making.
– Advarra’s focus on data-driven insights and automation capabilities with Braid aims to enhance study design, align protocols with operational realities, and reduce costs and timelines in clinical research.
– By fostering collaboration and connectivity among research stakeholders, Advarra breaks down barriers in the clinical trial ecosystem and accelerates the pace of trials with a commitment to innovation, ethics, and operational excellence.
Tags: regulatory, biopharma, clinical trials, automation
Read more on pharmabiz.com